2019 Program 

saturday, may 25, 2019

7:00 AM - 4:00
Registration Open

7:00 - 7:45 AM
Breakfast Symposia

Palliative Care in Patients with End-Stage Liver Disease/Cases
Cynthia Tsien, University of Ottawa

Difficult Cases in Treating Patients with Hepatitis C
Matthew Sadler, Foothills Medical Center & Curtis Cooper, University of Ottawa

7:00 - 8:00 AM
CASL Special Interest Group Meeting

• CanNASH
• To learn more about CanNASH click here

8:00 - 9:15 AM
Concurrent Sessions

• Public Heath: Innovative Approaches to Enhance Testing, Linkage to Care and Treatment for HCV Infection

  • Introduction and Setting the Scene
    Jason Grebely, Canadian Network on Hepatitis C and UNSW Sydney, Australia
  • Nurse Led HCV Micro-Elimination Outreach Project for People with Unstable Housing and Homelessness in Victoria BC
    Tamara Barnett, Cool Aid
  • Enhancing Care for HCV Infection in Prisons in Eastern Canada
    Lisa Barrett, Dalhousie University
  • Accelerated Pre-Treatment Evaluation for Persons who Inject Drugs Disengaged from the Healthcare System in Montréal
    Lisa Barrett, Dalhousie University

• Basic/Translational: Molecular Mechanisms of HCC in Viral and Non-Viral Hepatitis

  • Molecular mechanism of HCC in Viral Hepatitis
    Ralf Bartenschlager, Heidelberg University
  • Metabolic Profiling of HCC: In Vitro & In Vivo Models of HCC
    Marc Bilodeau, University of Montreal
  • The Role of the Inflammasome in Gastrointestinal Cancers and Liver Metastasis
    Maya Saleh, McGill University
  • New Medical Therapies for HCC
    Hélène Castel, University of Montreal 

9:20-10:15 
Concurrent Sessions 

• CAHN Sessions 

  • Welcome 
    Donna Zukowski, CAHN President
    Session Moderator: Mary Guyton
  • Nutrition in Liver Disease: Practical Counseling Tips
    Chantal Bemeur, University of Montreal 
  • Hepatic Encephalopathy: Nursing Interventions 
    Elizabeth Lee, University Health Network 

• Viral Hepatitis Oral Abstract Presentations

  • Incidence and Predictors of Flares after Stopping Nucleos(t)ide Analogue Therapy in HBeAg Negative Patients with Chronic Hepatitis B: Results from the Randomized Controlled STOP Study
    Scott Fung, Toronto Centre for Liver Disease
  • Global Real World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective Regimen for the Treatment of Chronic Hepatitis C patients: Integrated Analysis of 12 Clinical Practice Cohorts
    Alnoor Ramji, University of British Columbia
  • Results of a Birth Cohort Hepatitis C Screening Program in an Academic Emergency Department in Canada
    Camelia Capraru, Toronto Centre for Liver Disease/VIRCAN, UHN
  • Noninvasive Prediction of Esophageal Varices by Liver Stiffness Measurement and Platelet Count in 590 HIV-Infected Cirrhotic Patients With and Without HCV Coinfection: Multicenter Validation of Baveno VI Criteria
    Giada Sebastiani, McGill University
  • Prenatal HBsAg Screening Rates and Follow-up DNA Testing Low in Ontario
    Mia Biondi, Toronto General Hospital, UHN

10:15 - 10:45 AM
Break, Poster, & Exhibit Viewing

10:45 - 12:30 PM
Concurrent Session

• Mechanisms of Liver Injury & Repair in NAFLD & Viral Hepatitis 

  • Immunopathogenesis of Hepatitis B
    Adam Gehring, University of Toronto
  • Analysis of Virus Induced Mechanisms of Programmed Cell Death
    Rodney Russell, Memorial University
  • The Liver as Frontline Immune Organ
    Craig Jenne, University of Calgary
  • Insulin Signaling in NAFLD & NAFLD-related HCC
    Jennifer Estall, McGill University

• New Clinical Developments 

  • NAFLD
    Saumya Jayakumar, University of Calgary
  • Alcohol
    Gyongyi Szabo, University of Alberta Hospital
  • Viral Hepatitis
    Mark Sulkowski, Johns Hopkins Medicine
  • The Challenge of Fontan Associated Liver Disease
    Beverley Kok, University of Alberta Hospital

12:30 - 1:30 PM
Lunch, Poster & Exhibit Viewing 

1:30 - 3:00 PM
Concurrent Session

• Evolving Evidence in Liver Disease Pathogenesis and Best Clinical Management 

  • Novel Mechanisms Linking Blood Coagulation to Liver Injury and Regeneration
    Jim Luyendyke, Michigan State University
  • Overview of Hepatitis B Reactivation: Current Concepts, Molecular Mechanisms and Management
    Norah Terrault, USC Keck School of Medicine
  • Translational Research in Alcoholic Hepatitis from iTeam (NIH Consortium)
    Gyongyi Szabo, University of Massachusetts Medical School
  • HCV Treatment in HCC: Yes or No? A Debate
    David Wong, University of Toronto vs. Kelly Burak, University of Calgary

• Public Health and Best Practice Clinical Management

  • Nutrition Updates in NAFLD and Cirrhosis
    Maitreyi Raman, University of Calgary
  • Public Health Approaches In Childhood Obesity
    Shazhan Amed, University of British Columbia
  • Up-to-Date Diagnosis & Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension
    Samir Gupta, University of Toronto

3:00 - 3:30 PM
Break, Poster & Exhibit Viewing 

3:30 - 5:00 PM
CASL-CLF Sass-Kortsak Lecture & Pediatric Symposium

• CASL-CLF Sass-Kortsak Lecture
  Fernando Alvarez, CHU-Sainte Justine
• Biliary Atresia in Long-Term Kasai Survivors
  Richard Schreiber, University of British Columbia
• Primary Scelrosing Cholangitis
  Orlee Guttman, University of British Columbia
  Aldo Montano-Loza, University of Alberta
• Congenital Hepatic Fibrosis in the Long-Term Outcome of Autosomal Recessive Polycystic Kidney Disease
  Steve Martin, University of Calgary

3:30 - 4:30 PM
CAHN Session
HCV Models of Care Among Priority Populations: Nursing Practice and Pearls
Chair: Mia Biondi

• Prison System Dennaye Fuchs,
  Saskatchewan Health Authority
• Supervised Injection/Overdose Prevention
  Bernadette Lettner & Kate Mason, South Riverdale Community Health Centre
• Reaching Homeless Populations
  Jacqueline Atkinson, Mobile Outreach Street Health
• Newcomer HCV Linkage
  Jeanette Feizi Farivar, GI Research Institute

4:30 - 5:00 PM
The Next Liver Disease of Focus: Alcohol or NASH? A Debate
David Wong, University Health network
Edward Tam, Lair Centre Chair: Colina Yim, University Health Network

5:00 PM
CASL Annual General Meeting (CASL Members Only)